Introduction
Microbes have the unique capacity to acquire resistance to bacteriophages and plasmids through the incorporation of small DNA fragments (spacers) derived from these invaders into the genome of the infected cell 1, 2 . Cells that successfully incorporate these spacers in their CRISPR array become immunized against further infection by that specific invader 1, 2 . The inserted spacers are expressed and processed into CRISPR RNAs, and act as guides for Cas protein effector complexes that help the microbe find, bind and cleave matching invader nucleic acid sequences, resulting in invader elimination and host survival 2, 3 . To date, a number of evolutionarily diverse CRISPR-Cas systems have been identified and classified into two main classes (I and II) and six main types (I-VI) on the basis of their cas gene repertoire 4 . Because of the rarity of spacer-acquisition events, which are estimated to occur in 1 in 10 7 cells in some CRISPR-Cas systems 5, 6 , adaptation remains hard to observe. Spacer acquisition was shown first in the type II-A system of Streptococcus thermophilus 1 and subsequently in a number of type I systems 7, 8 , including the well-characterized type I-E system [9] [10] [11] . Some type III systems were shown to acquire spacers by converting RNA into DNA through a reverse-transcriptase mechanism 12 , but spacer acquisition in type III systems seems to be very rare.
Comparison to alternative approaches
Alternative methods to detect CRISPR spacer acquisition utilize the conserved aspects of CRISPR array structure and the spacer-acquisition mechanism. CRISPR loci generally comprise repeat-spacer arrays preceded by an AT-rich leader sequence, which acts as the transcriptional promoter and binding site for factors that assist with spacer acquisition 13 . Spacers are typically between 30 and 40 base pairs, and are inserted at the leader proximal end of the array duplicating the first repeat in the process 2 . The insertion of a spacer results in an increase in CRISPR array size, which can be assessed by PCR and harnessed as an indicator for acquisition events 5, 7, [9] [10] [11] . In addition to these conventional PCR approaches, reporter systems have been developed that give a detectable signal after spacer insertion due to a frameshift 14, 15 . Although these reporter systems provide a quantifiable and sensitive method of detection, their reliance on a frameshift requires strain engineering and limits the number of CRISPR types and systems this technique is applicable to 14, 15 methods are simple and user-friendly but often lack the sensitivity that is required to study many aspects of CRISPR adaptation.
Advances in the study of adaptation were made in parallel with the increasing availability of deep sequencing, which allowed the detection of spacer acquisition in minor fractions of the bacteria present in the population 7 . However, massive sequencing efforts suffer from high levels of noninformative PCR amplicons, representing unexpanded CRISPR arrays from cells that did not acquire new spacers. In recently published work, the method SENECA was developed to eliminate such unexpanded arrays from sequencing samples. This method requires the presence of an engineered restriction endonuclease site flanking the first repeat, which can be harnessed to prevent PCR amplification of unexpanded CRISPR arrays in a second PCR round 16 . Here we present a general strategy, termed CAPTURE, that can be adapted to any native CRISPR array. The method has been applied in recently published work from our lab 17 and builds on, combines and improves existing tricks to selectively amplify expanded CRISPR arrays 5, 7, [9] [10] [11] . Our method harnesses two PCR steps separated by automated electrophoresis and extraction of size-selected DNA amplicons, allowing the removal of unexpanded arrays from the sample pool ( Fig. 1 ). After this, PCR reamplification of the captured DNA pool with spacer-acquisition-specific primers allows visible detection of spacer acquisition in just 1 in 10 5 cells (0.001%) in the population, and potentially up to 1 in 10 8 cells after deep sequencing. This method enables the direct study of CRISPR-Cas systems with low acquisition rates, which seems to be a common feature of a large number of bacteria and archaea 5, 6 .
Potential applications
The study of CRISPR adaptation reveals the physical interactions of hosts with their invaders, and can be used in computational methods to couple viral invaders to unknown hosts and to track spaceracquisition events over time in sequenced strains 18, 19 . Because each bacterial strain has a different history, differences in spacer content can be used to distinguish closely related pathogenic strains, such as Mycobacterium and Yersinia species 20 . Typically, only a small fraction of spacers can be Step 5
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Steps 20-31 mapped back to known invaders, which suggests that there is a vast amount of unexplored invader diversity in nature 19 . Aside from strain typing, the sequence of new spacers provides mechanistic information that can be used, for example, to identify the protospacer-adjacent motif (PAM), a critical sequence motif in the DNA that authenticates DNA for cleavage by Cas proteins in type I, II and V CRISPR systems and prevents self-targeting of the CRISPR array [7] [8] [9] [10] [11] 17 . We aimed to develop a highly sensitive, simple and generally applicable method that could be used to detect the occurrence of such rare spacer acquisition events and unravel further mechanistic details of uncharacterized CRISPR systems. The use of CAPTURE can provide a wealth of information about both uncharacterized, newly discovered and well-known CRISPR systems. The method helps to elucidate the role of Cas proteins, the identity of the PAM, the preferred spacer substrates of Cas1/Cas2 and the minimal requirements for both adaptation and defense, as exemplified by the work of Kieper et al., who recently uncovered the role of the Cas4 protein in adaptation 17 .
Limitations
The CAPTURE method requires a gel extraction machine or more laborious manual extraction methods 7 . To both increase the utility of this protocol as a tool for the detection of spacer acquisition and remove unexpanded CRISPR arrays, multiple PCR amplification steps are required. Reamplification in PCR 2 with primer sets 2, 3 or 4 may introduce PCR bias, which prohibits the use of absolute abundance levels of new spacers with high confidence. Typically, only unique spacer sequences are used for downstream analysis (Table 1) . It is therefore important that all users take this into consideration when analyzing sequencing results. The removal of duplicates during the processing of sequencing reads is recommended and ensures that reamplification bias will not influence the prevalence of certain spacer sequences in the population. We advise users to consider using biological triplicates and to compare the results obtained from all unique and nonunique spacers. If degenerate primers are used, it is possible to carry out normalization to correct for the bias introduced by the fixed 3′ nucleotides of the primer 21 . This allows the user to draw accurate conclusions about the prevalence of certain spacers in the population. 
Experimental design
This protocol contains a series of steps involving size selection and extraction in combination with two PCR amplifications, PCR 1 and PCR 2. The options provided for these steps can be used in various combinations, both to determine whether the CRISPR adaptation module in your strain is active and to aid the preparation of a deep-sequencing sample containing a majority of arrays that have acquired spacers. Not all steps of the protocol need to be completed if the desired outcome can be reached at an earlier step ( Figs. 1 and 2 ). Before using this protocol, one should carefully consider the primer design and reamplification options, as these will differ depending on both the CRISPR array of the strain used and further actions to be taken with the final sample (Fig. 2, Supplementary Fig. 1 and Supplementary Table 1 ).
PCR 1: amplifying CRISPR arrays from a population (Step 4)
The described protocol is designed with the assumption that some sequence knowledge or metagenomics data have been obtained previously for the bacterial strain or population of interest. Exact sequence information of the CRISPR array to be studied is required for the primer-design step. Primers for PCR 1, the initial array amplification, must be specifically designed for each strain to bind within the leader sequence and, where possible, within the closest known spacer to the leader, as the sequences of both binding sites can differ greatly between species and subtypes of the CRISPR system. Careful design of primer set 1 allows for amplification of all expanded arrays present in the population, as well as the elimination of all repeats downstream from spacer 1 (Fig. 3) . The elimination of excess repeats is important for later steps of the protocol because if a second reamplification is required, the primer set may bind the repeats specifically, resulting in amplification only when a new spacer is inserted and two repeats are present. We include primers for the type I-E CRISPR system of Escherichia coli BW25113 as an example of the primers that can be designed (Supplementary Fig. 1 and Supplementary Table 1) .
Size-selection and extraction parameters (Steps 8-14)
In addition to considering which part of the CRISPR array is amplified, it is also important to consider the amplified array product size in relation to the following size-selection and extraction steps. Smaller bands will allow a higher degree of size separation during use of the BluePippin Can you design repeat primers for your system? (see Supplementary Fig. 1 and Supplementary Table 1) PCR 2(C) Reamplification of size-extracted fragments using repeat primers (set It is likely that your system is not active or cannot acquire spacers under the current conditions cassette. The highest percentage of agarose available in a BluePippin cassette is 3%, which allows selection in the range of 100-250 bp. This equally applies to users completing the size selection and extraction manually from an agarose gel. For manual extraction, we recommend using a 3% (wt/vol) agarose gel to increase expanded and unexpanded array separation. After this, the expanded array band must be excised from the gel, extracted and purified. For optimal selection of only the expanded arrays, we suggest that both the gel electrophoresis separation and subsequent DNA extraction be completed twice 7 .
Controls (all steps)
We recommend using an unexpanded (native) array control sample throughout the entire procedure to allow assessment of the size extraction success and the proportion of unexpanded arrays in the final DNA sample. The control should be the same as the CRISPR array of the strain of interest, in which the reverse primer (e.g., primer 2) will bind in the most leader-proximal spacer (Supplementary Fig. 1 and Supplementary Table 1) . Either the parental strain with no new spacers or a synthetic DNA construct with the sequence of the unexpanded array could be used as the control throughout this protocol. Use of the original strain of interest as a control can begin at Step 1 with the samples to be tested. A synthetic DNA control should be added as a separate sample during size extraction (Steps 8-15). Such a control determines the carryover of the unexpanded arrays for the size selection and extraction and allows for optimization of the parameters for both use of the BluePippin and manual extraction (Fig. 4) . The control also aids in the identification of PCR amplification artifacts that can arise owing to unspecific annealing temperatures for primer binding or the creation of larger PCR amplicons from internal binding of the repeats. These artifacts can appear as expanded arrays in the control after size selection and can be removed with small optimizations (Table 2) .
PCR 2: reamplification after size selection (Step 17)
Reamplification is an important additional step in this protocol, as often the initial amplification (PCR 1) is not sensitive enough to detect acquisition occurring at a low frequency in the population (Fig. 4) . In addition, when high-frequency spacer acquisition can be detected in PCR 1, there are often still a large number of unexpanded arrays present in the sample, and these unexpanded arrays can mask low-frequency acquisition events that are later revealed after size selection and reamplification (Fig. 5) . In this protocol, through size selection and reamplification, we aim to maximize both the ) is greatly increased after size selection (right) compared with that in the control (C).
detection limit and the number of expanded array sequences obtained from deep sequencing. There are three options (Step 17A-C) using primer sets 2, 3 and 4, respectively, for the second amplification step (PCR 2) of this method. The three primer sets we refer to as internal primers (set 2), degenerate primers (set 3) and repeat primers (set 4) should be carefully designed according to the desired output, subsequent plans for the sample pool and sequence analyses (Figs. 2 and 5, Supplementary  Fig. 1 and Supplementary Table 1 ). The internal primers (set 2) allow reamplification of the expanded arrays, thus enabling confirmation of successful spacer acquisition taking place in just 1 in 10 3 cells in the population of interest (Fig. 6a) . The degenerate primers (set 3) allow extremely sensitive detection of acquisition at an occurrence of just 1 in 10 5 cells (Fig. 6b ). This amplification is based on the use of three forward primers; these primers anneal their 3′ nucleotide only with new spacers beginning with a nucleotide different from the original spacer 5 ( Fig. 5, Supplementary Fig. 1 ). The repeat primer (set 4) strategy ensures that the short 60-bp array products can be amplified only in the presence of two repeats (i.e., an expanded array); this process relies on the removal of a repeat during the first PCR amplification but allows high-sensitivity detection of acquisition occurring in just 1 in 10 5 cells and a final sample population ready for further sequencing (Figs. 5 and 6c).
Sequencing (Steps 20-31)
A user may choose to sequence new spacers to determine spacer length distribution (can be consistent or variable) or spacer source (bacteriophage genome, plasmid or host genome), or to retrieve the PAM of the newly acquired spacers. Deep sequencing may be used to increase the sensitivity at which new spacers are detected, to enable the discovery of rare spacer acquisition events. When deep sequencing is carried out, it is advisable to reamplify expanded PCR amplicons using the CAPTURE method to minimize the presence of nonexpanded CRISPR array amplicons. A user may choose not to sequence new spacers by following the protocol up to and including Step 15, when only general spacer-acquisition activity is monitored over time, or, for example, when trying to answer questions about the general effect of cas gene mutants on the spacer-acquisition activity.
Fig. 5 | Primer design options for reamplification of expanded CRISPR arrays. Schematic of the three possible primer options for the second PCR amplification step. The internal primers (left) bind in spacer 1 (primer 2) and the leader sequence (3) internally of primer 1 used in the first PCR step before size selection. The degenerate primers (middle) consist of three forward primers (DP) that anneal their 3′ nucleotide only with new spacers (orange) starting with a nucleotide different from the original spacer (blue), in combination with primer 2. The repeat primers (right) bind within the repeat (7 and 8) oriented such that a product is amplified only when two repeats are present, that is, the array is expanded. ) and 1:10 6 (10 −6 ) expanded:unexpanded CRISPR arrays plus an unexpanded control (0) were compared and visualized on a 2% (wt/vol) agarose gel after completion of Step 15, reamplification after size selection. a, Reamplification with internal primers (option A). b, Reamplification with degenerate primers (option B). c, Reamplification with repeat-binding primers (option C). The black arrow labeled +1 indicates the expected fragment size when the array has expanded. Here it is shown that while the internal primers (a) have a low sensitivity to detect acquisition, occurring in at least 1% of the entire bacterial population, CAPTURE with the more specific degenerate primers (b) and repeat primers (c) is able to detect acquisition events that occurred in just 0.001% of the population.
Materials Biological materials
• E. coli K12 BW25113 (parental strain; KEIO Collection, National BioResource Project (NBRP) E. coli strain)
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• E. coli PIM5, a variant of the KEIO strain E. coli K12 JW12252 (ref.
10 ; Brouns lab collection) ! CAUTION Use gloves and a lab coat when working with biological samples. c CRITICAL The protocol described below permits the use of any bacterial strain in which sequence information of the CRISPR array is known or is suspected to be similar to that of a known array, to allow the primer design. c CRITICAL If you do not have the BluePippin machine on offer in your facility, gel extraction of the expanded arrays can be done manually via concentration of the DNA samples for each condition. This is followed by manual gel extraction; the entire sample, including 1 μl of loading dye per 6 μl of sample, should be loaded in a 3% (wt/vol) agarose gel and run at 100 V for~1 h to maximize band separation. The expanded array (larger) band should be excised from the gel as accurately as possible, and the DNA should be extracted with the GeneJET gel extraction kit. The manual gel extraction can be repeated a second time to further remove the remaining unexpanded arrays.
Reagents
• Qubit 4 fluorometer (Thermo Fisher Scientific, cat. no. Q33226) • Qubit assay tubes (Thermo Fisher Scientific, cat. no. Q32856) • DynaMag-96 bottom magnet (magnetic stand; Thermo Fisher Scientific, cat. no. 12332D)
Reagent setup
Fresh LB medium To produce 1 liter of the medium, weigh 5 g/l yeast extract, 10 g/l NaCl and 10 g/l tryptone and mix well with 800 ml of distilled H 2 O. After mixing thoroughly, add the final 200 ml of distilled H 2 O. The medium must then be sterilized by autoclaving at 121°C for 20 min and can be stored at room temperature for up to 1 month.
Degenerate primer master mix
To create the degenerate primer master mix used in Step 17, mix the three forward degenerate primers containing differing 3′ nucleotides that do not match the existing spacer in your system (see 'Experimental design' and Supplementary Table 1) equally to give a final concentration of~3.3 µM of each primer and a total concentration of 10 µM. The primer master mix can be stored at −20°C in a freezer indefinitely.
1× TAE buffer
Dilute a 40× TAE buffer stock with Milli-Q H 2 O. 1× TAE buffer can be stored at room temperature for a recommended maximum of 3 years.
Agarose gels
Prepare fresh gels when needed by combining agarose and 1× TAE buffer (wt/vol). The most commonly used gels in this protocol are 2%, that is, 1 g of agarose and 50 ml of 1× TAE. Mix and heat these components for~1 min. Then add 5 µl of SYBR Safe (10,000×) to allow visualization of the DNA and pour into a gel mold with a comb. Leave to set for at least 10 min.
Procedure
Preparation of samples for use as PCR templates • Timing~12-13 h 1 Set up an overnight culture of your strain of interest at the optimal temperature for growth (for our cultures, this is 37°C, at 180 r.p.m.). 2 (Optional) Extract the genomic DNA of your sample using the GeneJET genomic DNA extraction kit according to the supplied protocol. Elute the DNA in 200 µl of molecular-biology-grade H 2 O, or less if a low concentration is expected. c CRITICAL STEP If your sample is acquired from the environment or a different source, there may be a more appropriate kit for this step. c CRITICAL STEP Genomic extraction is recommended when your sample has a low cell density or may contain contaminants that will affect subsequent PCR reactions. 3 (Optional) Measure the DNA concentration in nanograms per microliter with a NanoPhotometer. j PAUSE POINT DNA can be stored at 4°C overnight or frozen at −20°C for long-term storage (i.e., indefinitely).
Amplification of CRISPR arrays present in the sample population • Timing~4 h
4 Using either the overnight culture from Step 1 directly or the sample prepared in optional Steps 2 and 3 as a template, prepare a PCR reaction as follows: c CRITICAL STEP If you are using an overnight culture as a template for the initial PCR, increasing your denaturation time to 5 min at 98°C can aid cell lysis by making more genomic DNA available as a template in the PCR reaction tube. 5 Run the PCR products (5-10 µl) on a 2% (wt/vol) agarose gel containing SYBR Safe (1 µl/10 ml) at 100 V for~30 min to check for the presence of a single band of your desired size (gel extraction or PCR optimization is needed if more bands are present). c CRITICAL STEP The gel percentage can be adapted for your expected fragment size. A higher percentage of agarose allows for greater separation of smaller bands. ? TROUBLESHOOTING 6 Clean and concentrate the PCR(s) using the GeneJET PCR purification kit, following the manufacturer's instructions. Elute in 30 µl of molecular-biology-grade H 2 O. c CRITICAL STEP Add isopropanol in a proportion equal to that of the DNA binding buffer when purifying fragments smaller than 500 bp. c CRITICAL STEP The PCR reaction must be purified and H 2 O must be used during the elution of samples from kits, as salts in the PCR reaction or elution buffer can interfere in future steps carried out in the BluePippin machine. 7 Measure the concentration of DNA (nanograms per microliter) on the NanoPhotometer. In the next few steps, large quantities of DNA can be lost, so a concentration of at least 30 ng/µl in 30 µl is advised; run additional PCRs and pool if more DNA is needed. c CRITICAL STEP Between 20% and 50% of the DNA sample can be lost during the BluePippin process, so it is better to load as much as possible without exceeding the maximum of 5 µg of DNA. j PAUSE POINT DNA can be stored at 4°C overnight or frozen at −20°C indefinitely.
Size selection and extraction of expanded arrays • Timing~3 h c CRITICAL In the absence of the BluePippin, manual extraction of the expanded arrays from a gel will take~4 h. 8 Depending on the size (or sizes if multiple spacers were acquired) of your arrays visualized in
Step 5, choose an appropriate BluePippin cassette. For arrays between 100 and 250 bp, the 3% gel cassette with Internal Standards Marker Q3 is advised. 9 Calibrate the BluePippin machine as described in the Sage Science BluePippin Operations Manual. 10 Load your cassette of choice into the machine, exchange the elution buffer and check buffer levels as described in the Sage Science BluePippin Operations Manual. c CRITICAL STEP The loading buffer must be at room temperature before use in the BluePippin gel cassette. 11 Prepare your samples for loading into the BluePippin (final volume: 40 µl) by adding 10 µl of assigned marker or loading solution. c CRITICAL STEP This step is cassette dependent. c CRITICAL STEP Samples should be vortexed well and spun down before loading. The loading solution contains a densifying agent that will allow the sample to sink below the electrophoresis buffer layer in the well, thus increasing the size-selection accuracy. c CRITICAL STEP The fluorescein labels (on the DNA marker) will degrade at room temperature; minimize the time that the labels spend on the bench, or keep them on ice. 12 Program the selection range as outlined in the Sage Science BluePippin Operations Manual to collect the size range in which all expanded arrays are included. c CRITICAL STEP Programming a wider selection range can improve the DNA yield (e.g.,~20 bp on either side of your desired fragment size). 13 Load the samples slowly into appropriate lanes and run the program as described in the Sage Science BluePippin Operations Manual.
14 Collect the DNA extracted for the defined size range from the elution chamber. 15 (Optional) Visualize the DNA by gel electrophoresis (Fig. 4) . Run the extracted DNA products (5-10 μl) on a 2% (wt/vol) agarose gel containing SYBR Safe (1 µl/10 ml) at 100 V for~30 min and image to check for the presence of expanded arrays. c CRITICAL STEP
Step 15 should be carried out if users simply desire to check whether their CRISPR system actively incorporates new spacers. Visualization of the extracted products allows confirmation of the ability to acquire spacers, and can be followed by optional deep sequencing. c CRITICAL STEP If the user desires to carry out deep sequencing without further reamplification, she or he should carry out Step 15. Visualization of the extracted products allows assessment of the success of the extraction and verification of the presence of expanded arrays in the sample before sequencing. ? TROUBLESHOOTING 16 Measure the concentration of DNA from Step 14 with the NanoPhotometer to assess which step needs to be taken next (see Fig. 2 and 'Experimental design'). c CRITICAL STEP If your DNA concentration is high enough immediately after Step 16 to be used as input DNA for next-generation sequencing (NGS) library preparation with your kit of choice, it is possible to proceed directly to sequencing (Step 20) . However, it is important to note that higher starting concentrations are often recommended for library preparation kits, as DNA can be lost when magnetic beads are used. ? TROUBLESHOOTING j PAUSE POINT DNA can be stored at 4°C overnight or frozen at −20°C indefinitely.
Reamplification of the size-selected arrays to increase detection sensitivity • Timing~2 h 17 Use the size-selected DNA fragments as template DNA for a PCR amplification with one of the primer sets outlined in the 'Experimental design' section 'PCR 2: reamplification after size selection' (Fig. 5, Supplementary Fig. 1 and Supplementary Table 1 ). Follow option A for reamplification with internal primers, option B for reamplification with degenerate primers or option C for reamplification with repeat primers. Option A should be used when a high acquisition rate is observed for your strain (Fig. 6a) . Options B and C (degenerate and repeat primers, respectively) are useful for detecting rare events, enabling sensitive detection on the gel, further detection through deep sequencing and removing the unexpanded background (Fig. 6b,c) . However, only option C maintains full spacer diversity (Table 1) . c CRITICAL STEP The primer set must be system specific and chosen carefully; see details in the 'Experimental design' section and recommendations below. Perform PCR amplification under the following conditions (conditions must be adapted to your specific primers and/or product length): Visualizing spacer acquisition by gel electrophoresis • Timing~45 min 18 Run the PCR products (5-10 µl) on a 2% (wt/vol) agarose gel containing SYBR Safe (1 µl/10 ml) at 100 V for~30 min to check for the presence of a single band of your desired size (gel extraction or PCR optimization is needed if more bands are present). ? TROUBLESHOOTING 19 Assess whether adaptation has occurred (i.e., look for the presence of a band with the expected size) and, when NGS is planned, assess whether your sample pool has a greater proportion of expanded arrays than the unexpanded control array (Fig. 6 ).
NGS to investigate spacer content (optional) • Timing~1 d for sample library preparation, 1-2 d for sequencing,~5 d for analysis c CRITICAL Sequencing of samples with an NGS platform allows for even greater detection and, more important, sequence-specific information for the spacers acquired in the population. There are many kits and sequencing platforms that could be used to sequence expanded array PCR amplicons; below, we use our lab's preferences. 20 and, where available, a Bioanalyzer (fragment size and molar concentration). 24 If you will be sequencing your sample in-house, following the guidelines for your sequencing instrument (here MiSeq), pool all barcoded sample libraries at the desired proportions to the recommended final concentration (here 2 nM). Denature your sample with an equal amount of freshly diluted 0.2 N NaOH and dilute to the appropriate loading concentration and volume for the flow cell, following the Illumina guidelines for the specific platform. c CRITICAL STEP The entire sample is not required for sequencing, and it is therefore recommended to set aside a portion of your sample library before dilution and denaturation and keep it at −20°C for up to 1 week. c CRITICAL STEP Use equimolar amounts of all barcoded libraries to maintain equal depth among all samples sequenced. c CRITICAL STEP The recommended loading concentration will differ for each sequencing machine. The recommended concentration for the MiSeq is 6-10 pM; here we used 4 pM, as we loaded very small fragments that cluster more efficiently than the recommended minimum 250-bp fragments. j PAUSE POINT The prepared sample library can be stored for up to 1 week at -20°C until sequencing is carried out. 25 Following the specific instructions for the sequencing instrument, load the appropriately diluted sample into the reagent cartridge. Next, clean and load the flow cell into the machine, check for any additional solutions required and start the run. Alternatively, frozen libraries prepared as described above can be sent out for custom sequencing. 26 For analysis of the sequencing data for each sample, the sequences must be quality-assessed, normalized, merged where necessary and demultiplexed (separated by unique barcodes into samples). This can be carried out at a basic level by the sequencing instrument itself, or you can use a software package or more detailed pipeline 7, 17, 21 . 27 After demultiplexing, for each sample, extract all spacer-containing sequences by identifying conserved CRISPR array regions, such as the 3′ end of the degenerate primer and the 5′ end of the repeat. Extract the sequences flanked by these regions as spacer sequences 23 . 28 To assess spacer content, align the extracted sequences to potential spacer sources such as the host genome or other known factors in the cell such as plasmids, or, when the potential sources are unknown, screen the sequences with BLAST (Basic Local Alignment Search Tool) or other sequence databases 24 . 29 After extraction of all spacer sequences, remove duplicate spacers to determine the number of unique spacers acquired and to remove the duplication bias created by PCR amplification. In addition, apply normalization to the sequences if any form of degenerate primer was used for reamplification in PCR 2 (Table 1) 21 . 30 Determine the orientation of the extracted spacers to enable extraction of the PAM-containing nucleotides adjacent to the target sequence 7, 17, 25 . Web tools such as WebLogo can then be used to further aid the determination of the strongest PAM sequence for the system of interest 9, 26 . 31 Finally, analyze the spacer content (nucleotide sequence) and length of the extracted sequences and compare between conditions 17 .
Troubleshooting
Troubleshooting advice can be found in Table 2 .
Timing
Step 1, overnight growth:~12 h Steps 2 and 3 (optional), genomic DNA extraction: 1 h
Step 4, PCR amplification: 3 h Steps 5-7, gel electrophoresis and purification of sample: 1 h Steps 8-14, extraction of expanded arrays: 2 h 
Anticipated results
The outlined protocol provides a method for the detection of spacers acquired by active CRISPR systems even at extremely low levels. To test the sensitivity of CAPTURE, we mimicked a population in which only a small fraction of the cells had acquired one new spacer. To achieve this, we used both the wild-type strain E. coli K12 BW25113 containing a type I-E CRISPR system 27 , and a variant of this strain known to contain an extra 32-bp spacer 10 , referred to as unexpanded and expanded, respectively (Fig. 3) . The low prevalence of acquisition was simulated by the serial dilution of genomic DNA extracted from the expanded strain to 10 −6 in DNA extracted from the unexpanded strain. Such a dilution series allowed us to test the true sensitivity of our method by simulating acquisition rates as low as 1 in 10 6 expanded arrays (0.0001% of the population) with an upper limit of 1 in 10 expanded arrays (10% of the population) acquiring a spacer (Fig. 6 ). In our experience, if all steps are followed, this procedure can detect spacers acquired in just 1 in 10 5 cells of a population (Fig. 6 ), and this sensitivity can be increased even further with subsequent deep sequencing of the prepared sample 17 .
Reporting Summary
Further information on research design is available in the Nature Research Reporting Summary linked to this article. 
Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested 
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